Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of vinflunine + gemcitabine versus paclitaxel + gemcitabine in unresectable locally recurrent or metastatic breast cancer after prior adjuvant anthracycline-based chemotherapy
2006-001139-23Phase 3Completed
- Sponsor
- Pierre Fabre Laboratories
- Start
- May 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in breast cancer comparing Vinflunine + gemcitabine with Paclitaxel + gemcitabine (2 arms). Primary endpoints: Progression-free survival, Non-inferiority of progression-free survival and 1 more. Started May 2006; status: completed.
02
Drugs
vinfluninegemcitabinepaclitaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2006-001139-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001139-23.